Literature DB >> 35176400

Scoping review of the relationship between diabetes and voice quality.

Mohammad Ali Saghiri1, Anna Vakhnovetsky2, Julia Vakhnovetsky3.   

Abstract

AIMS: The objective of this scoping review is to synthesize all of the known information about the relationship between diabetes mellitus and voice quality and to explore its potential applications for new technology.
METHODS: We conducted a scoping literature review of articles published between March 2000 and September 2021 using the following databases: PubMed, Web of Science, Scopus, and Embase. Additionally, we did a manual search of Google Scholar. The search strategy abides by the PRISMA-ScR guidelines. Studies pertaining to the relationship between diabetes and the voice were categorized separately for further evaluation.
RESULTS: Out of the 2732 originally identified articles, nine were ultimately included in this scoping review. The chosen articles address both diabetes and its impact on a variety of vocal parameters.
CONCLUSIONS: There is currently very little research investigating the relationship between diabetes, neuropathy, and phonatory symptoms. Additionally, existing publications contain some contradictory findings. Further research that incorporates imaging technology is needed to clarify the physiological explanations for the differences observed between healthy individuals and those with diabetes mellitus. Such information can be used to develop noninvasive technology for diabetes diagnosis and monitoring.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus; Dysphonia; Glucose monitoring; Voice

Mesh:

Year:  2022        PMID: 35176400     DOI: 10.1016/j.diabres.2022.109782

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  1 in total

1.  The effect of type 1 diabetes mellitus on voice in pediatric patients.

Authors:  Irfan Kara; Fatih Temiz; Adem Doganer; Saime Sagıroglu; Muhammed Gazi Yıldız; Nagihan Bilal; Israfil Orhan
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-07-13       Impact factor: 3.236

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.